Cytokinetics Inc. buy Cantor Fitzgerald
Start price
09.09.24
/
50%
€50.00
Target price
09.09.25
-
Performance (%)
-13.20%
End price
10.09.25
€43.40
Summary
This prediction ended on 10.09.25 with a price of €43.40. The price of Cytokinetics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.20%. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cytokinetics Inc. | -1.912% | -1.912% | 119.434% |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten